Cargando…
A therapeutic role for mesenchymal stem cells in acute lung injury independent of hypoxia-induced mitogenic factor
Bone marrow mesenchymal stem cells (BM-MSCs) have therapeutic potential in acute lung injury (ALI). Hypoxia-induced mitogenic factor (HIMF) is a lung-specific growth factor that participates in a variety of lung diseases. In this study, we evaluated the therapeutic role of BM-MSC transplantation in...
Autores principales: | Song, Lin, Xu, Jinfu, Qu, Jieming, Sai, Yin, Chen, Chunmei, Yu, Long, Li, Dechun, Guo, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823300/ https://www.ncbi.nlm.nih.gov/pubmed/21477220 http://dx.doi.org/10.1111/j.1582-4934.2011.01326.x |
Ejemplares similares
-
Hypoxia pretreatment enhances the therapeutic potential of mesenchymal stem cells (BMSCs) on ozone-induced lung injury in rats
por: Abdelrahman, Shaimaa A., et al.
Publicado: (2022) -
Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury
por: Liu, Yung-Yang, et al.
Publicado: (2017) -
Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/β-catenin
por: Yang, Xiaotong, et al.
Publicado: (2020) -
VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-κB signaling pathway
por: Tong, Qiangsong, et al.
Publicado: (2006) -
Fibroblast Growth Factor-10 (FGF-10) Mobilizes Lung-resident Mesenchymal Stem Cells and Protects Against Acute Lung Injury
por: Tong, Lin, et al.
Publicado: (2016)